United States - Re-Export of Heparin for Therapeutic Use
Since 2014, United States Re-Export of Heparin for Therapeutic Use fell by 29.7% year on year. In 2019, the country was number 1 comparing other countries in Re-Export of Heparin for Therapeutic Use with $4,598,060.57. Canada, Barbados and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +141.8% per year, while United States was the worst growing country at -29.7% per year.
| Date | US Dollars |
|---|---|
| 2019 | 4,598,060.57 |
| 2018 | 4,847,742.00 |
| 2017 | 7,638,412.00 |
| 2016 | 2,732,125.00 |
| 2015 | 5,521,158.00 |
Download all data from 1991 to 2019
How does United States rank in Re-Export of Heparin for Therapeutic Use?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
4,598,060.57 | 2019 | -5.2 % | -29.7 % | View data |
| 2 |
#2
Canada
|
728,579.06 | 2019 | +2.9 % | +13.3 % | View data |
| 3 |
#3
Barbados
|
212,328.10 | 2019 | +12.0 % | +14.6 % | View data |
| 4 |
#4
Saudi Arabia
|
173,620.88 | 2016 | -45.1 % | NA | View data |
| 5 |
#5
Jordan
|
114,511.44 | 2019 | -6.3 % | -22.7 % | View data |